Trials / Completed
CompletedNCT02650219
Auto-antibodies Prevalence and CD1 Role in Gaucher Disease
Prevalence of Autoantibodies in the Gaucher Disease and the Role of CD1 Molecules in Immune Manifestations of This Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Hospital St. Joseph, Marseille, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Hypergammaglobulinaemia is frequently observed in type 1 Gaucher disease (GD1), being either polyclonal or monoclonal gammopathies. Polyclonal hypergammaglobulinemia may be related to the presence of autoantibodies. The clinical significance of such antibodies is questioned in Gaucher disease (GD), as some cases of immunologic thrombocytopenia and autoimmune hemolytic anemia have also been reported. Objectives: To evaluate the prevalence of autoantibodies and autoimmune diseases in GD1 patients, we conducted a multicenter national study. The investigators investigated whether there was a link between splenectomy, genotype, therapeutic options and the presence of these autoantibodies.They also investigated whether there was a correlation with some clinical manifestations of GD1
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | genetic analyses |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2016-01-08
- Last updated
- 2016-03-23
- Results posted
- 2016-01-08
Locations
11 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02650219. Inclusion in this directory is not an endorsement.